EKSO
Price
$0.65
Change
-$0.04 (-5.80%)
Updated
Jan 17 closing price
Capitalization
24.35M
39 days until earnings call
NMTC
Price
$1.05
Change
+$0.01 (+0.96%)
Updated
Jan 17 closing price
Capitalization
30.86M
30 days until earnings call
Ad is loading...

EKSO vs NMTC

Header iconEKSO vs NMTC Comparison
Open Charts EKSO vs NMTCBanner chart's image
Ekso Bionics Holdings
Price$0.65
Change-$0.04 (-5.80%)
Volume$604.15K
Capitalization24.35M
NeuroOne Medical Technologies
Price$1.05
Change+$0.01 (+0.96%)
Volume$190.09K
Capitalization30.86M
EKSO vs NMTC Comparison Chart
Loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKSO vs. NMTC commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSO is a Hold and NMTC is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (EKSO: $0.65 vs. NMTC: $1.05)
Brand notoriety: EKSO and NMTC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EKSO: 44% vs. NMTC: 80%
Market capitalization -- EKSO: $24.35M vs. NMTC: $30.86M
EKSO [@Medical Specialties] is valued at $24.35M. NMTC’s [@Medical Specialties] market capitalization is $30.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKSO’s FA Score shows that 1 FA rating(s) are green whileNMTC’s FA Score has 0 green FA rating(s).

  • EKSO’s FA Score: 1 green, 4 red.
  • NMTC’s FA Score: 0 green, 5 red.
According to our system of comparison, both EKSO and NMTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKSO’s TA Score shows that 3 TA indicator(s) are bullish while NMTC’s TA Score has 5 bullish TA indicator(s).

  • EKSO’s TA Score: 3 bullish, 4 bearish.
  • NMTC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NMTC is a better buy in the short-term than EKSO.

Price Growth

EKSO (@Medical Specialties) experienced а -17.43% price change this week, while NMTC (@Medical Specialties) price change was -7.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

EKSO is expected to report earnings on Apr 30, 2025.

NMTC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMTC($30.9M) has a higher market cap than EKSO($24.3M). NMTC YTD gains are higher at: 27.134 vs. EKSO (6.803). EKSO (-13.2M) and NMTC (-13.34M) have comparable annual earnings (EBITDA) . EKSO has more cash in the bank: 8.64M vs. NMTC (2.68M). NMTC has less debt than EKSO: NMTC (154K) vs EKSO (7.17M). EKSO has higher revenues than NMTC: EKSO (18.3M) vs NMTC (2.82M).
EKSONMTCEKSO / NMTC
Capitalization24.3M30.9M79%
EBITDA-13.2M-13.34M99%
Gain YTD6.80327.13425%
P/E RatioN/AN/A-
Revenue18.3M2.82M650%
Total Cash8.64M2.68M322%
Total Debt7.17M154K4,655%
FUNDAMENTALS RATINGS
EKSO vs NMTC: Fundamental Ratings
EKSO
NMTC
OUTLOOK RATING
1..100
5039
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6539
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (30) in the Medical Specialties industry is in the same range as NMTC (62) in the null industry. This means that EKSO’s stock grew similarly to NMTC’s over the last 12 months.

EKSO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NMTC (100) in the null industry. This means that EKSO’s stock grew similarly to NMTC’s over the last 12 months.

EKSO's SMR Rating (98) in the Medical Specialties industry is in the same range as NMTC (100) in the null industry. This means that EKSO’s stock grew similarly to NMTC’s over the last 12 months.

NMTC's Price Growth Rating (39) in the null industry is in the same range as EKSO (65) in the Medical Specialties industry. This means that NMTC’s stock grew similarly to EKSO’s over the last 12 months.

NMTC's P/E Growth Rating (100) in the null industry is in the same range as EKSO (100) in the Medical Specialties industry. This means that NMTC’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKSONMTC
RSI
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
85%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 12 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
90%
View a ticker or compare two or three
Ad is loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGN224.235.32
+2.43%
Align Technology
NNBR2.650.05
+1.92%
NN
HOOK1.950.01
+0.52%
HOOKIPA Pharma Inc.
ASGN88.45-0.86
-0.96%
ASGN
EDN32.98-0.35
-1.05%
Empresa Distribuidora Y Comercializadora Norte SA

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and ATEC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and ATEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
-5.72%
ATEC - EKSO
25%
Poorly correlated
+2.48%
GENE - EKSO
25%
Poorly correlated
N/A
ICLR - EKSO
24%
Poorly correlated
-2.15%
MASS - EKSO
24%
Poorly correlated
+2.76%
CDNA - EKSO
23%
Poorly correlated
-2.81%
More

NMTC and

Correlation & Price change

A.I.dvisor tells us that NMTC and INBS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NMTC and INBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMTC
1D Price
Change %
NMTC100%
+0.95%
INBS - NMTC
24%
Poorly correlated
+6.11%
XAIR - NMTC
22%
Poorly correlated
+11.57%
NUWE - NMTC
21%
Poorly correlated
+11.52%
MBOT - NMTC
21%
Poorly correlated
-7.87%
EKSO - NMTC
21%
Poorly correlated
-5.72%
More